Correction: <i>Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE</i>
Crossref DOI link: https://doi.org/10.1136/lupus-2018-000286corr1
Published Online: 2018-12-22
Published Print: 2018-12
Update policy: https://doi.org/10.1136/crossmarkpolicy
